HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The initial results of fetoscopic laser treatment for severe second trimester twin-to-twin transfusion syndrome in the Netherlands are comparable to international results].

AbstractOBJECTIVE:
Evaluation of the initial results of selective fetoscopic laser coagulation of placental blood vessels for severe second-trimester twin-to-twin transfusion syndrome in the Netherlands.
DESIGN:
Prospective cohort study.
METHOD:
Between August 2000 and December 31, 2002, 49 patients were included with severe second-trimester twin-to-twin transfusion syndrome. Treatment took place in the Leiden University Medical Centre and consisted of selective fetoscopic laser coagulation of anastomoses along the vascular equator on the placental surface. Follow-up was complete until six weeks after delivery.
RESULTS:
Median gestational age was 20 weeks at fetoscopy and 34 weeks at birth. Perinatal survival rate was 65% (64/98). The treatment resulted in at least one surviving child in 80% of pregnancies.
CONCLUSION:
The results of fetoscopic laser treatment for severe second-trimester twin-to-twin transfusion syndrome in the Netherlands are similar to the recent results in specialised foreign centres.
AuthorsJ M Middeldorp, F J Klumper, D Oepkes, E Lopriore, H H Kanhai, F P Vandenbussche
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 148 Issue 24 Pg. 1203-8 (Jun 12 2004) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleEerste resultaten in Nederland van foetoscopische laserbehandeling bij tweelingtransfusiesyndroom in het tweede trimester van de zwangerschap vergelijkbaar met internationale resultaten.
PMID15224433 (Publication Type: English Abstract, Journal Article)
Topics
  • Cohort Studies
  • Female
  • Fetal Diseases (mortality, surgery)
  • Fetofetal Transfusion (mortality, surgery)
  • Fetoscopy (methods)
  • Humans
  • Laser Coagulation (methods)
  • Placenta (blood supply, surgery)
  • Pregnancy
  • Pregnancy Trimester, Second
  • Prospective Studies
  • Survival Rate
  • Treatment Outcome
  • Twins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: